4 patents
Utility
Methods of treating erythropoietic protoporphyria, X-linked protoporphyria, or congenital erythropoietic porphyria with glycine transport inhibitors
14 Nov 23
The present embodiments are directed to methods of using glycine transporter inhibitors, such as GlyT1 inhibitors, or pharmaceutically acceptable salts, solvates or prodrugs thereof, or pharmaceutical compositions thereof, for preventing or treating erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLPP), and/or congenital erythropoietic porphyria (CEP), and related syndromes thereof.
Brian Richard MacDonald, Maria Gabriela Beconi, Vu Hong
Filed: 8 Jan 21
Utility
Matriptase 2 Inhibitors and Uses Thereof
9 Feb 23
The present invention provides compounds for inhibiting matriptase 2, or a mutant thereof, and compositions and methods of use thereof.
Srikanth Venkatraman, Subhendu Mukherjee, Rajeev Goswami, Venkateshwar Rao Gummadi, A. Bharathi Raja, Martuza Hadianawala
Filed: 2 Oct 19
Utility
zia1f2uvpcfv62p51qm1zy9inx eiwb
2 Dec 21
The present disclosure provides compositions and methods for treating, preventing, or inhibiting diseases of the eye.
James McLaughlin, Adarsha Koirala, Lisa Huang
Filed: 23 Oct 19
Utility
vaw1x0 znqtnf4ndydzdnr2ua3jwlnnachzhety6hwv5em0rs7oewuypkgm1
24 Jun 21
The present disclosure provides compositions and methods for treating, preventing, or inhibiting diseases of the eye.
James McLaughlin, Adarsha Koirala
Filed: 19 Oct 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first